|
|
New Original Clinical Research
Experience with Cancer Genetics Testing During COVID-19 at a Community Hospital
Allison Jay, MD, Hannah Kelley, BS, Susan M. Jay, MD
PDF HTML EPUB XML
DOI: https://doi.org/10.30953/thmt.v8.382
With the onset of the COVID-19 pandemic in 2020, the utilization of telemedicine offered an alternative diagnostic and treatment resource to providers in oncology and cancer genetics. This care option paired with genetic testing labs’ ability to send saliva-based DNA collection kits to patients enabled a community hospital in Detroit to offer diagnostic testing outside a health facility setting. Social determinants of health have been found to influence
success with telehealth. This study analyzed how successful telehealth cancer genetics care was throughout the Detroit Metro area.
What were the challenges of initiating a telemedicine program in an urban community serving cancer patients who may have economic and historically poor perceived technologic abilities?
Read findings at https://doi.org/10.30953/thmt.v8.382 |
ConVerge2Xcelerate (#ConV2X) Telehealth 2023 is HERE! Tired of mega events? Change your pace and opt for a curated intimate event to make meaningful connections with ACCESS
to thought leaders that get under the hood with different speakers and topics - and no chatting it up with cliques. You make headway with meaningful educational content and grow a new Michelin Star network.
Get TWO FULL DAYS of Live & Virtual programs now with Early Bird rates HERE.
Scotty is “beaming in” the first 3D Holographic Keynote from a decorated NASA practicing telehealth physician. We’re “holoporting” him from Kazakhstan, where is he is the medical lead for the Soyuz & Orion
manned missions!
Join us for the annual hybrid AI & Tech in Telehealth and Medicine 2023! |
|
|
|
|
